EntryPoint Capital’s Ocugen OCGN Stock Holding History

EntryPoint Capital’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-65,174	Closed	-$64.7K	–	900
2024 Q3	$64.7K	Buy	+65,174	New	+$89.5K	0.04%	575

Other funds holding OCGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

EntryPoint Capital's OCGN Position: Q4 2024 in Review

EntryPoint Capital sold out of Ocugen (OCGN) in Q4 2024, closing a stake of 65,174 shares — an estimated $64.7K sold.

EntryPoint Capital first reported a position in OCGN in Q3 2024 and held it in 1 quarter. The position peaked at $64.7K in Q3 2024. 114 funds tracked by Wall St. Rank hold OCGN as of Q4 2024.

EntryPoint Capital reported no remaining Ocugen position as of Q4 2024 after selling out during the quarter.
EntryPoint Capital sold 65,174 Ocugen shares in Q4 2024, an estimated $64.7K.
EntryPoint Capital first reported a position in Ocugen in Q3 2024 and held it in 1 quarter.
EntryPoint Capital's Ocugen position peaked at $64.7K in Q3 2024.
114 funds tracked by Wall St. Rank held Ocugen as of Q4 2024.

Based on EntryPoint Capital's 13F filing for Q4 2024, filed 11 Feb 2025.